Electronic Health Record Strategies to Promote Diverse Participation in Research AIM 2
- Conditions
- Patient Participation
- Registration Number
- NCT06467487
- Lead Sponsor
- Yale University
- Brief Summary
Based on the outcomes of the initial study (NCT05348603), this optimization study will employ the most effective interventions (letters and messages) and distribute these communications to underrepresented minorities to further promote interest in research. Optimized language will be distributed in English, Spanish, Portuguese, Chinese, Arabic, or Haitian Creole, based on preferred language identified in the patient profile in an electronic medical records system.
- Detailed Description
The primary objective of the optimization study is to examine the effectiveness on increasing interest in research of an optimized letter versus a generic letter; an optimized message versus a generic message; and an optimized letter and an optimized message versus a generic letter and a generic message.
The secondary objective of the optimization study is to examine the effectiveness on increasing participation in research of an optimized letter versus a generic letter, an optimized message versus a generic message, an optimized letter and an optimized message versus a generic letter and a generic message.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 214526
- Has an account with the online patient portal
- Has logged into the online patient portal at least once in the past year
- Has not set up a research profile
- Currently enrolled in a clinical trial
- Opted out of research
- On active cancer treatment
- Active member of the study team
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Number of patients who create a research profile 12 months The outcome will be assessed by querying the patient's electronic medical record to determine whether the patient has registered in the Yale University Volunteer Database. This database is comprised of patients who agree to be contacted if there is a study at Yale that meets their interests.
- Secondary Outcome Measures
Name Time Method Number of patients who enroll in a research study 12 months The outcome will be assessed by querying our clinical trials management system or electronic health record system to determine if the patient has consented to participate in a research study.
Trial Locations
- Locations (1)
Yale University
🇺🇸New Haven, Connecticut, United States
Yale University🇺🇸New Haven, Connecticut, United States